This compound is a pharmaceutical intermediate used in the manufacturing of Velpatasvir. It features a tetracyclic structure with acetyl and ketone functional groups, contributing to its role in the synthesis of this antiviral agent.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1438383-92-6
3-(2-bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
Pharmaceutical intermediate for synthesis
(5s)-1-(tert-butoxycarbonyl)-5-methyl-l-proline
Pharmaceutical intermediate for Velpatasvir
1,2-Pyrrolidinedicarboxylic acid, 4-cyano-, 1-(1,1-dimethylethyl) 2-methyl ester, (2S,4S)-
Pharmaceutical intermediate for Velpatasvir
1,2-Pyrrolidinedicarboxylic acid, 4-(methoxymethyl)-, 1-(1,1-dimethylethyl) 2-[2-oxo-2-(8,9,10,11-tetrahydro-8-oxo-5H-benzo[d]naphtho[2,3-b]pyran-3-yl)ethyl] ester, (2S,4S)-
Pharmaceutical intermediate for Velpatasvir
2-((6,11-Dihydro-5H-dibenzo[b,e]azepin-6-yl)methyl)isoindoline-1,3-dione
pharmaceutical intermediate
(R)-1-Boc-3-hydroxypiperidine
Pharmaceutical intermediate for drug synthesis
Tert-butyl (3S)-3-hydroxypiperidine-1-carboxylate
pharmaceutical intermediate for ibrutinib
(R)-4-(3-Isopropoxyphenyl)-1,3-dimethyl-1,2,3,6-tetrahydropyridine
Pharmaceutical intermediate
3-acetyl-5,9,10,11-tetrahydronaphtho[7,6-c]isochromen-8-one
HEDVCJIUEKLCCV-UHFFFAOYSA-N
CC(=O)C1=CC2=C(C=C1)C3=C(C=C4C(=C3)CCCC4=O)OC2
—